Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)

Clinical trial NCT02946879 · COMPLETED

Trial details

NCT number: NCT02946879
Sponsor: MeiraGTx UK II Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Leber Congenital Amaurosis (LCA)Eye Diseases Eye Diseases, Hereditary Retinal Diseases

Start date: 2016-11-01
Primary completion: 2023-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.